| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 3: Daly Richard J, Director
Holds 0 shares of Common Stock |
| 10 Apr 2026 |
Form 3: Zalewski Thomas A., Chief Legal Officer
Holds 0 shares of Common Stock |
| 11 Mar 2026 |
Form 3: Greenhawt Matthew J., Chief Medical Officer
Holds 2,000 shares of Common Stock |
| 12 Nov 2025 |
Form 3: Davis Matthew W., Chief Development Officer
No securities owned |
| 07 May 2025 |
Form 3: Cioffi Melina, SVP Regulatory Affairs
Holds 182,261 shares of Common Stock |
| 11 Jun 2024 |
Form 3: Korczynski Sherry, SVP Sales and Marketing
Holds 0 shares of Common Stock |
| 26 Apr 2024 |
Form 3: Jenkins Abigail L., Director
Holds 0 shares of Common Stock |
| 30 Jun 2023 |
Form 3: Kraus Carl N, CHIEF MEDICAL OFFICER
Holds 0 shares of Common Stock |
| 11 Jan 2023 |
Form 3: Jung Cassie, SVP, Operations
Holds 36,747 shares of Common Stock |
| 11 Jan 2023 |
Form 3: Wargacki Stephen, SVP, Research & Development
Holds 26,956 shares of Common Stock |
| 22 Feb 2021 |
Form 3: Taglietti Marco, Director
No securities owned |
| 19 Feb 2021 |
Form 3: Krop Julie, Director
No securities owned |
| 08 Jan 2021 |
Form 3: Toth A Ernest Jr, Interim CFO
No securities owned |
| 07 Jan 2019 |
Form 3: Slatko Gary H, SVP, Chief Medical Officer
No securities owned |
| 13 Sep 2018 |
Form 3: Braender Lori J, SVP, General Counsel
No securities owned |
| 26 Jul 2018 |
Form 3: Monoline Partners, L.p., 10% owner
Holds 165,000 shares of Common Stock |
| 24 Jul 2018 |
Form 3: Schobel Alexander Mark, Director
Holds 1,000,000 shares of Common Stock |
| 24 Jul 2018 |
Form 3: Boyd Peter E., SVP-Operations/Value Delivery
Holds 49,439 shares of Common Stock |
| 24 Jul 2018 |
Form 3: Scibetta James S, Director
Holds 8,664 shares of Common Stock |
| 24 Jul 2018 | Form 3: Lurker Nancy, Director |
Loading...